Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2023 Filed Sep 5, 2023 21:53 UTC |
SHELTON JERRELLDirector · See Remarks
|
Exercise / conversionOption to purchase common stock · Derivative | 54,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001104659-23-098352 · tm2325535d1_4seq1.xml · derivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,007 Underlying: Common Stock · 54,000 shares Expires 2026-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48 of the options vested on the 6th of each month for forty-eight months beginning on May 6, 2016. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 21:53 UTC |
SHELTON JERRELLDirector · See Remarks
|
SaleCommon Stock | 26,875 | $14.27 | $383,406.81 |
DisclosureSEC source: 0001104659-23-098352 · tm2325535d1_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 632,424 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.09 to $14.36, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 21:53 UTC |
SHELTON JERRELLDirector · See Remarks
|
Exercise / conversionCommon Stock | 54,000 | $1.87 | $100,980.00 |
DisclosureSEC source: 0001104659-23-098352 · tm2325535d1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 659,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 21:30 UTC |
STEFANOVICH ROBERTChief Financial Officer
|
Exercise / conversionOptions to purchase common stock · Derivative | 16,000 | $0.00 Strike: $3.07 | $0.00 |
DisclosureSEC source: 0001104659-23-096929 · tm2325164-1_4.xml · derivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,164 Underlying: Common Stock · 16,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48 of the options vested on the 20th of each month for forty-eight months beginning on August 19, 2015. Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 21:30 UTC |
STEFANOVICH ROBERTChief Financial Officer
|
Exercise / conversionCommon Stock | 16,000 | $3.07 | $49,120.00 |
DisclosureSEC source: 0001104659-23-096929 · tm2325164-1_4.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: No Common Stock was sold by the reporting person in connection with the transactions disclosed on this Form 4. Read SEC document |
| May 12, 2023 Filed May 16, 2023 19:26 UTC |
BERMAN RICHARD JDirector
|
GrantOption (Right to Buy Common Stock) · Derivative | 15,125 | $0.00 Strike: $20.05 | $0.00 |
DisclosureSEC source: 0001104659-23-061518 · tm2316016-1_4seq1.xml · derivative · entry 2 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,125 Underlying: Common Stock · 15,125 shares Expires 2030-05-12 F2 · derivative.exercise_date: 1/12th of the options vest on the 12th of the month for twelve months beginning June 12, 2023. Read SEC document |
| May 12, 2023 Filed May 16, 2023 19:26 UTC |
BERMAN RICHARD JDirector
|
GrantCommon Stock | 8,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-061518 · tm2316016-1_4seq1.xml · nonDerivative · entry 1 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,105 F1 · security: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. F1 · price: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:28 UTC |
BADDOUR LINDADirector
|
GrantOption (Right to Buy Common Stock) · Derivative | 15,125 | $0.00 Strike: $20.05 | $0.00 |
DisclosureSEC source: 0001104659-23-061523 · tm2316016-6_4seq1.xml · derivative · entry 2 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,125 Underlying: Common Stock · 15,125 shares Expires 2030-05-12 F2 · derivative.exercise_date: 1/12th of the options vest on the 12th of the month for twelve months beginning June 12, 2023. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:28 UTC |
BADDOUR LINDADirector
|
GrantCommon Stock | 8,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-061523 · tm2316016-6_4seq1.xml · nonDerivative · entry 1 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,579 F1 · security: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. F1 · price: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:28 UTC |
ZECCHINI EDWARD JDirector
|
GrantOption (Right to Buy Common Stock) · Derivative | 15,125 | $0.00 Strike: $20.05 | $0.00 |
DisclosureSEC source: 0001104659-23-061522 · tm2316016-5_4seq1.xml · derivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,125 Underlying: Common Stock · 15,125 shares Expires 2030-05-12 F2 · derivative.exercise_date: 1/12th of the options vest on the 12th of the month for twelve months beginning June 12, 2023. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:28 UTC |
ZECCHINI EDWARD JDirector
|
GrantCommon Stock | 8,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-061522 · tm2316016-5_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,039 F1 · security: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. F1 · price: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:28 UTC |
Mandalam RamkumarDirector
|
GrantOption (Right to Buy Common Stock) · Derivative | 15,125 | $0.00 Strike: $20.05 | $0.00 |
DisclosureSEC source: 0001104659-23-061521 · tm2316016-4_4seq1.xml · derivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,125 Underlying: Common Stock · 15,125 shares Expires 2030-05-12 F2 · derivative.exercise_date: 1/12th of the options vest on the 12th of the month for twelve months beginning June 12, 2023. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:28 UTC |
Mandalam RamkumarDirector
|
GrantCommon Stock | 8,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-061521 · tm2316016-4_4seq1.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,016 F1 · security: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. F1 · price: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:27 UTC |
Hariri Robert JDirector
|
GrantOption (Right to Buy Common Stock) · Derivative | 15,125 | $0.00 Strike: $20.05 | $0.00 |
DisclosureSEC source: 0001104659-23-061520 · tm2316016-3_4seq1.xml · derivative · entry 2 Hariri Robert J · CIK 0001398815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,125 Underlying: Common Stock · 15,125 shares Expires 2030-05-12 F2 · derivative.exercise_date: 1/12th of the options vest on the 12th of the month for twelve months beginning June 12, 2023. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:27 UTC |
Hariri Robert JDirector
|
GrantCommon Stock | 8,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-061520 · tm2316016-3_4seq1.xml · nonDerivative · entry 1 Hariri Robert J · CIK 0001398815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,016 F1 · security: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. F1 · price: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:27 UTC |
HANCOCK DANIEL MDirector
|
GrantOption (Right to Buy Common Stock) · Derivative | 15,125 | $0.00 Strike: $20.05 | $0.00 |
DisclosureSEC source: 0001104659-23-061519 · tm2316016-2_4seq1.xml · derivative · entry 2 HANCOCK DANIEL M · CIK 0001764017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,125 Underlying: Common Stock · 15,125 shares Expires 2030-05-12 F2 · derivative.exercise_date: 1/12th of the options vest on the 12th of the month for twelve months beginning June 12, 2023. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:27 UTC |
HANCOCK DANIEL MDirector
|
GrantCommon Stock | 8,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-061519 · tm2316016-2_4seq1.xml · nonDerivative · entry 1 HANCOCK DANIEL M · CIK 0001764017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,643 F1 · security: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. F1 · price: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. Read SEC document |
| May 11, 2023 Filed May 12, 2023 18:22 UTC |
BERMAN RICHARD JDirector
|
SaleCommon Stock | 7,203 | $21.51 | $154,906.28 |
DisclosureSEC source: 0001104659-23-059933 · tm2315733-3_4seq1.xml · nonDerivative · entry 1 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.39 to $21.68, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:22 UTC |
SHELTON JERRELLDirector · President, CEO
|
Exercise / conversionOption to purchase common stock · Derivative | 286,377 | $0.00 Strike: $3.24 | $0.00 |
DisclosureSEC source: 0001104659-23-059932 · tm2315733-2_4seq1.xml · derivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 286,377 shares Expires 2023-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options vested over four years in 48 equal installments beginning 7/28/2013. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:22 UTC |
SHELTON JERRELLDirector · President, CEO
|
SaleCommon Stock | 141,159 | $21.63 | $3,053,509.14 |
DisclosureSEC source: 0001104659-23-059932 · tm2315733-2_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 605,299 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.50 to $21.92, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:22 UTC |
SHELTON JERRELLDirector · President, CEO
|
Exercise / conversionCommon Stock | 286,377 | $3.24 | $927,861.48 |
DisclosureSEC source: 0001104659-23-059932 · tm2315733-2_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 746,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:21 UTC |
STEFANOVICH ROBERTChief Financial Officer
|
Exercise / conversionOptions to purchase common stock · Derivative | 19,918 | $0.00 Strike: $3.24 | $0.00 |
DisclosureSEC source: 0001104659-23-059931 · tm2315733-1_4seq1.xml · derivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,918 shares Expires 2023-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options vested over four years in 48 equal installments beginning 7/28/2013. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:21 UTC |
STEFANOVICH ROBERTChief Financial Officer
|
SaleCommon Stock | 19,918 | $21.94 | $437,022.83 |
DisclosureSEC source: 0001104659-23-059931 · tm2315733-1_4seq1.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,150 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.575 to $22.27, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:21 UTC |
STEFANOVICH ROBERTChief Financial Officer
|
Exercise / conversionCommon Stock | 19,918 | $3.24 | $64,534.32 |
DisclosureSEC source: 0001104659-23-059931 · tm2315733-1_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 127,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 22:00 UTC |
STEFANOVICH ROBERTChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 20,910 | $0.00 Strike: $23.78 | $0.00 |
DisclosureSEC source: 0001104659-23-036715 · tm2310574-3_4seq1.xml · derivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,910 Underlying: Common Stock · 20,910 shares Expires 2030-03-22 F2 · derivative.exercise_date: 1/48 of options vest on the 22nd of each month for forty-eight months beginning 4/22/2023. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 22:00 UTC |
STEFANOVICH ROBERTChief Financial Officer
|
GrantCommon Stock | 10,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-036715 · tm2310574-3_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,150 F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024. F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 22:00 UTC |
SHELTON JERRELLDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 60,952 | $0.00 Strike: $23.78 | $0.00 |
DisclosureSEC source: 0001104659-23-036713 · tm2310574-2_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,952 Underlying: Common Stock · 60,952 shares Expires 2030-03-22 F2 · derivative.exercise_date: 1/48 of options vest on the 22nd of each month for forty-eight months beginning 4/22/2023. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 22:00 UTC |
SHELTON JERRELLDirector · Chief Executive Officer
|
GrantCommon Stock | 27,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-036713 · tm2310574-2_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 460,081 F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024. F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 22:00 UTC |
Sawicki Mark WChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 20,910 | $0.00 Strike: $23.78 | $0.00 |
DisclosureSEC source: 0001104659-23-036712 · tm2310574-1_4seq1.xml · derivative · entry 2 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,910 Underlying: Common Stock · 20,910 shares Expires 2030-03-22 F2 · derivative.exercise_date: 1/48 of options vest on the 22nd of each month for forty-eight months beginning 4/22/2023. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 22:00 UTC |
Sawicki Mark WChief Scientific Officer
|
GrantCommon Stock | 10,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-036712 · tm2310574-1_4seq1.xml · nonDerivative · entry 1 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,125 F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024. F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:16 UTC |
BADDOUR LINDADirector
|
Exercise / conversionRestricted Stock Rights · Derivative | 1,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-033874 · tm239899-4_4seq1.xml · derivative · entry 2 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,111 Underlying: Common Stock · 1,111 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The originally granted restricted stock rights vest in three equal annual installments beginning March 15, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 15, 2023. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F2 · derivative.exercise_date: The originally granted restricted stock rights vest in three equal annual installments beginning March 15, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 15, 2023. F2 · derivative.expiration_date: The originally granted restricted stock rights vest in three equal annual installments beginning March 15, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 15, 2023. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:16 UTC |
BADDOUR LINDADirector
|
Exercise / conversionCommon Stock | 1,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-033874 · tm239899-4_4seq1.xml · nonDerivative · entry 1 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:15 UTC |
Sawicki Mark WChief Scientific Officer
|
SaleCommon Stock | 1,362 | $20.79 | $28,315.98 |
DisclosureSEC source: 0001104659-23-033873 · tm239899-3_4seq1.xml · nonDerivative · entry 1 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,670 F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:15 UTC |
SHELTON JERRELLDirector · Chief Executive Officer
|
SaleCommon Stock | 2,599 | $20.79 | $54,033.21 |
DisclosureSEC source: 0001104659-23-033870 · tm239899-2_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,989 F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:15 UTC |
STEFANOVICH ROBERTChief Financial Officer
|
SaleCommon Stock | 1,069 | $20.79 | $22,224.51 |
DisclosureSEC source: 0001104659-23-033868 · tm239899-1_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,695 F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 01:25 UTC |
STEFANOVICH ROBERTChief Financial Officer
|
SaleCommon Stock | 1,159 | $20.14 | $23,342.26 |
DisclosureSEC source: 0001104659-23-031941 · tm239488d3_4.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,764 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 01:24 UTC |
Sawicki Mark WChief Scientific Officer
|
SaleCommon Stock | 1,476 | $20.14 | $29,726.64 |
DisclosureSEC source: 0001104659-23-031940 · tm239488d2_4.xml · nonDerivative · entry 2 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,032 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 01:23 UTC |
SHELTON JERRELLDirector · Chief Executive Officer
|
SaleCommon Stock | 3,798 | $20.14 | $76,491.72 |
DisclosureSEC source: 0001104659-23-031939 · tm239488d1_4.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,588 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights Read SEC document |
| March 09, 2023 Filed Mar 14, 2023 01:25 UTC |
STEFANOVICH ROBERTChief Financial Officer
|
Exercise / conversionRestricted Stock Rights · Derivative | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031941 · tm239488d3_4.xml · derivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,333 Underlying: Common Stock · 2,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. Read SEC document |
| March 09, 2023 Filed Mar 14, 2023 01:25 UTC |
STEFANOVICH ROBERTChief Financial Officer
|
Exercise / conversionCommon Stock | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031941 · tm239488d3_4.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| March 09, 2023 Filed Mar 14, 2023 01:24 UTC |
Sawicki Mark WChief Scientific Officer
|
Exercise / conversionRestricted Stock Rights · Derivative | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031940 · tm239488d2_4.xml · derivative · entry 3 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,333 Underlying: Common Stock · 2,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. Read SEC document |
| March 09, 2023 Filed Mar 14, 2023 01:24 UTC |
Sawicki Mark WChief Scientific Officer
|
Exercise / conversionCommon Stock | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031940 · tm239488d2_4.xml · nonDerivative · entry 1 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| March 09, 2023 Filed Mar 14, 2023 01:23 UTC |
SHELTON JERRELLDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Rights · Derivative | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031939 · tm239488d1_4.xml · derivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 8,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. Read SEC document |
| March 09, 2023 Filed Mar 14, 2023 01:23 UTC |
SHELTON JERRELLDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031939 · tm239488d1_4.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 06:07 UTC |
BERMAN RICHARD JDirector
|
SaleCommon Stock | 7,250 | $19.63 | $142,316.05 |
DisclosureSEC source: 0001104659-22-124319 · tm2231929d1_4seq1.xml · nonDerivative · entry 1 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 0 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.43 to $19.78, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 16, 2022 Filed Aug 16, 2022 18:29 UTC |
BERMAN RICHARD JDirector
|
SaleCommon Stock | 2,708 | $43.05 | $116,588.34 |
DisclosureSEC source: 0001104659-22-091872 · tm2223624-2_4seq1.xml · nonDerivative · entry 1 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,203 Read SEC document |
| August 11, 2022 Filed Aug 16, 2022 22:27 UTC |
Hariri Robert JDirector
|
SaleCommon Stock | 2,000 | $43.29 | $86,581.40 |
DisclosureSEC source: 0001104659-22-091871 · tm2223624-1_4seq1.xml · nonDerivative · entry 1 Hariri Robert J · CIK 0001398815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,911 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.26 to $43.325, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 30, 2022 Filed May 3, 2022 20:00 UTC |
BERMAN RICHARD JDirector
|
Exercise / conversionRestricted Stock Rights · Derivative | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-055435 · tm2214402-1_4seq1.xml · derivative · entry 3 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date. F2 · derivative.expiration_date: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date. Read SEC document |
| April 30, 2022 Filed May 3, 2022 20:00 UTC |
BERMAN RICHARD JDirector
|
Exercise / conversionCommon Stock | 2,708 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-055435 · tm2214402-1_4seq1.xml · nonDerivative · entry 2 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date. Read SEC document |
| April 30, 2022 Filed May 4, 2022 00:02 UTC |
ZECCHINI EDWARD JDirector
|
Exercise / conversionRestricted Stock Rights · Derivative | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-055440 · tm2214402-5_4seq1.xml · derivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date. F2 · derivative.expiration_date: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.